1. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization.
- Author
-
Arias L, Caminal JM, Rubio M, Pujol O, and Arruga J
- Subjects
- Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Bevacizumab, Choroidal Neovascularization etiology, Fluorescein Angiography, Humans, Macular Degeneration complications, Male, Pigment Epithelium of Eye pathology, Retinal Perforations diagnosis, Tomography, Optical Coherence, Vascular Endothelial Growth Factor A, Visual Acuity, Vitreous Body, Angiogenesis Inhibitors administration & dosage, Antibodies, Monoclonal administration & dosage, Choroidal Neovascularization drug therapy, Injections adverse effects, Pigment Epithelium of Eye injuries, Retinal Perforations etiology
- Abstract
Purpose: To detect retinal pigment epithelium (RPE) tears in predominantly classic choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) treated with intravitreal bevacizumab injections., Methods: Forty consecutive patients with predominantly classic CNV secondary to AMD were treated with 1.25 mg of intravitreal bevacizumab. Patients were evaluated with visual acuity (VA) measured with Early Treatment Diabetic Retinopathy Study charts, optical coherence tomography, and fluorescein angiography., Results: Three patients developed a RPE tear after the first injection. The first patient had been treated with verteporfin therapy and VA remained unchanged. In the other two cases the CNV was naive and VA improved since the foveal center was not involved by the tear and macular edema was reduced., Conclusions: RPE tears can occur following intravitreal bevacizumab injections in patients with predominantly classic CNV although VA is not always affected.
- Published
- 2007
- Full Text
- View/download PDF